Cardiol Therapeutics Inc. (TSX:CRDL)

Cardiol Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	27.67	21.42	30.58	34.93	59.47	83.9
Cash & Short-Term Investments	27.67	21.42	30.58	34.93	59.47	83.9
Cash Growth	18.81%	-29.97%	-12.46%	-41.26%	-29.12%	498.20%
Accounts Receivable	-	-	-	-	-	0.07
Other Receivables	0.34	0.23	0.36	0.28	0.48	0.34
Receivables	0.34	0.23	0.36	0.28	0.48	0.41
Prepaid Expenses	3.25	1.86	0.73	0.94	1.49	2.83
Total Current Assets	31.27	23.5	31.67	36.15	61.44	87.14
Property, Plant & Equipment	0.14	0.12	0.2	0.34	0.3	0.36
Other Intangible Assets	-	-	-	0.21	0.29	0.38
Total Assets	31.41	23.62	31.86	36.7	62.03	87.88

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	3.42	3.48	6.98	7.62	8.35	4.14
Accrued Expenses	-	-	-	0.42	0.99	0.72
Current Portion of Leases	0.04	0.04	0.03	0.02	0.05	0.04
Other Current Liabilities	3.67	2.14	-	0.24	0.42	6.66
Total Current Liabilities	7.13	5.66	7.01	8.3	9.8	11.57
Long-Term Leases	0.08	0.09	0.13	0.16	0.02	0.07
Total Liabilities	7.2	5.74	7.14	8.45	9.83	11.64

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	212.8	201.87	179.34	148.52	147.55	142.92
Additional Paid-In Capital	32.47	29.08	24.65	18.79	15.59	12.66
Retained Earnings	-223.89	-213.07	-179.25	-142.58	-114.45	-83.52
Comprehensive Income & Other	2.82	-	-	3.52	3.52	4.18
Shareholders' Equity	24.2	17.88	24.73	28.25	52.2	76.24
Total Liabilities & Equity	31.41	23.62	31.86	36.7	62.03	87.88

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.12	0.13	0.16	0.17	0.07	0.12
Net Cash (Debt)	27.56	21.29	30.42	34.76	59.4	83.78
Net Cash Growth	19.08%	-30.01%	-12.47%	-41.48%	-29.10%	504.11%
Net Cash Per Share	0.29	0.24	0.43	0.54	0.95	1.94
Filing Date Shares Outstanding	115.27	111.87	82.61	68.27	64.1	61.93
Total Common Shares Outstanding	111.87	100.26	82.61	65.35	64.04	61.92
Working Capital	24.14	17.85	24.66	27.86	51.63	75.58
Book Value Per Share	0.22	0.18	0.30	0.43	0.82	1.23
Tangible Book Value	24.2	17.88	24.73	28.04	51.91	75.86
Tangible Book Value Per Share	0.22	0.18	0.30	0.43	0.81	1.23
Machinery	0.46	0.41	0.39	0.42	0.35	0.28
Leasehold Improvements	0.24	0.24	0.24	0.24	0.24	0.24

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 6, 2026

Data Sources Report a data error